These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12699061)

  • 1. Molecular characterization of breast cancer aggressiveness.
    Biglia N; De Bortoli M
    Int J Biol Markers; 2003; 18(1):36-9. PubMed ID: 12699061
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular assays to predict prognosis of breast cancer.
    Paik S
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):681-2. PubMed ID: 17982408
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of breast cancer by array comparative genomic hybridization.
    Climent J; Garcia JL; Mao JH; Arsuaga J; Perez-Losada J
    Biochem Cell Biol; 2007 Aug; 85(4):497-508. PubMed ID: 17713584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The state of HER-2 status.
    Di Leo A
    Ann Oncol; 2007 May; 18(5):813-5. PubMed ID: 17488732
    [No Abstract]   [Full Text] [Related]  

  • 5. Microarrays in primary breast cancer--lessons from chemotherapy studies.
    Lønning PE; Sørlie T; Perou CM; Brown PO; Botstein D; Børresen-Dale AL
    Endocr Relat Cancer; 2001 Sep; 8(3):259-63. PubMed ID: 11566617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular classification of breast tumors: toward improved diagnostics and treatments.
    Sørlie T
    Methods Mol Biol; 2007; 360():91-114. PubMed ID: 17172726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
    Zabouo G; Imbert AM; Jacquemier J; Finetti P; Moreau T; Esterni B; Birnbaum D; Bertucci F; Chabannon C
    Breast Cancer Res; 2009; 11(1):R1. PubMed ID: 19123925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Multiparameter Tests for Identifying Women with Early Breast Cancer Who Do Not Need Adjuvant Chemotherapy.
    Duffy MJ; McDermott EW; Crown J
    Clin Chem; 2017 Apr; 63(4):804-806. PubMed ID: 28188230
    [No Abstract]   [Full Text] [Related]  

  • 9. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis.
    Creighton CJ; Casa A; Lazard Z; Huang S; Tsimelzon A; Hilsenbeck SG; Osborne CK; Lee AV
    J Clin Oncol; 2008 Sep; 26(25):4078-85. PubMed ID: 18757322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-expression signatures in breast cancer.
    Sotiriou C; Pusztai L
    N Engl J Med; 2009 Feb; 360(8):790-800. PubMed ID: 19228622
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer prognostic markers in the post-genomic era.
    Pusztai L; Iwamoto T
    Breast Cancer Res Treat; 2011 Feb; 125(3):647-50. PubMed ID: 20464478
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tools of molecular biology. Diagnostic use of DNA arrays].
    Bertucci F; Xerri L
    Ann Pathol; 2000; 20 Suppl():S67-70. PubMed ID: 11261300
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular diagnosis of breast cancer].
    Hirano A
    J Nippon Med Sch; 2001 Oct; 68(5):419-21. PubMed ID: 11598627
    [No Abstract]   [Full Text] [Related]  

  • 15. Lost in translation--prognostic signatures for breast cancer.
    Pusztai L
    Nat Clin Pract Oncol; 2008 Jul; 5(7):363. PubMed ID: 18583992
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic profiling of breast cancer: from molecular portraits to clinical utility.
    Børresen-Dale AL
    Int J Biol Markers; 2003; 18(1):54-6. PubMed ID: 12699064
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular detection of breast cancer markers.
    Verbanac KM
    Mol Diagn; 2001 Jun; 6(2):73-7. PubMed ID: 11468692
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
    Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Mamessier E; Adélaïde J; Debono S; Houvenaeghel G; Maraninchi D; Viens P; Charpin C; Jacquemier J; Birnbaum D
    Cancer Res; 2006 May; 66(9):4636-44. PubMed ID: 16651414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology in breast cancer: should molecular classifiers be assessed by conventional tools or by gene expression arrays?
    Fumagalli D; Andre F; Piccart-Gebhart MJ; Sotiriou C; Desmedt C
    Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e58-69. PubMed ID: 22964299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Array-based DNA methylation profiling for breast cancer subtype discrimination.
    Van der Auwera I; Yu W; Suo L; Van Neste L; van Dam P; Van Marck EA; Pauwels P; Vermeulen PB; Dirix LY; Van Laere SJ
    PLoS One; 2010 Sep; 5(9):e12616. PubMed ID: 20830311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.